Challenges in IBD Research: Pragmatic Clinical Research
Open Access
- 16 May 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 25 (Supplement) , S40-S47
Abstract
Pragmatic clinical research is part of five focus areas of the Challenges in IBD research document, which also includes preclinical human IBD mechanisms, environmental triggers, novel technologies, and precision medicine. The Challenges in IBD research document provides a comprehensive overview of current gaps in inflammatory bowel diseases (IBD) research and delivers actionable approaches to address them. It is the result of multidisciplinary input from scientists, clinicians, patients, and funders, and represents a valuable resource for patient centric research prioritization. In particular, the pragmatic clinical research section is focused on highlighting gaps that need to be addressed in order to optimize and standardize IBD care. Identified gaps include: 1) understanding the incidence and prevalence of IBD; 2) evaluating medication positioning to increase therapeutic effectiveness; 3) understanding the utility of therapeutic drug monitoring (TDM); 4) studying pain management; and 5) understanding healthcare economics and resources utilization. To address these gaps, there is a need to emphasize the use of emerging data sources and real-world evidence to better understand epidemiologic and therapeutic trends in IBD, expanding on existing data to better understand how and where we should improve care. Proposed approaches include epidemiological studies in ethnically and geographically diverse cohorts to estimate incidence and prevalence of IBD and impact of diversity on treatment patterns and outcomes. The implementation of new clinical trial design and methodologies will be essential to evaluate optimal medication positioning, appropriate use of TDM in adults and children, and multidisciplinary approaches to IBD pain management and its impact on healthcare resources.Keywords
Funding Information
- Crohn’s & Colitis Foundation
This publication has 70 references indexed in Scilit:
- Data Enclaves for Sharing Information Derived From Clinical and Administrative Data2018
- Evaluating Health Technology Through Pragmatic TrialsJAMA, 2018
- Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial FibrillationJAMA, 2018
- Biosimilars in the Treatment of Inflammatory Bowel Disease: Supporting Evidence in 2017Current Treatment Options in Gastroenterology, 2018
- Direct Health Care Insurer and Out-of-Pocket Expenditures of Inflammatory Bowel Disease: Evidence from a US National SurveyDigestive Diseases and Sciences, 2012
- The US Food and Drug Administration's Sentinel Initiative: Expanding the horizons of medical product safetyPharmacoepidemiology and Drug Safety, 2012
- Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trendsInflammatory Bowel Diseases, 2011
- Update on the incidence and prevalence of Crohnʼs disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000Inflammatory Bowel Diseases, 2007
- Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStatistics in Medicine, 1998
- Explanatory and pragmatic attitudes in therapeutical trialsJournal of Chronic Diseases, 1967